Hey everyone! If you’re into NEPSE trading or looking for the best dividend stocks in Nepal, I’ve got exciting updates on Sanima Reliance Life Insurance (SRLI). This popular life insurance company in Nepal listed on the Nepal Stock Exchange just announced a nice cash dividend for shareholders. Let’s break it down in simple words!
Sanima Reliance Life Insurance Limited (SRLI) has proposed a 10.178% cash dividend from the fiscal year 2081/82. Yes, it’s all cash dividend – no bonus shares this time, but still a solid return for NEPSE investors in the insurance sector.
As of Ashad end 2082 BS, the company has a strong paid-up capital of Rs 5.01 Arba. This makes SRLI one of the key players in Nepal's life insurance market and a favorite in NEPSE insurance stocks.
Looking back:
- From FY 2080/81, SRLI gave a 9.2489% dividend (including 8% bonus shares and 1.2489% cash dividend).
- In FY 2079/80, they distributed 18.3811% bonus shares.
- But in FY 2078/79, there was no dividend announced.
The good news? This latest 10.178% cash dividend will be distributed after getting approval from the Nepal Insurance Authority and the upcoming AGM (Annual General Meeting).
If you’re holding SRLI shares on NEPSE, this could be a great boost to your share market portfolio! Life insurance companies in Nepal like Sanima Reliance are known for steady growth, especially after their merger (remember Sanima Life Insurance merged with Reliance Life Insurance?).
Keep an eye on NEPSE live updates, share prices, and dividend announcements for more opportunities in Nepal stock market. What do you think about this SRLI dividend? Will it push the SRLI share price higher? Drop your thoughts below!
Stay tuned for more NEPSE news, stock analysis, and tips on dividend stocks Nepal!
Disclaimer
Meroshare.net is an independent website and is not affiliated with CDSC, NEPSE, SEBON, or the official MeroShare platform. For account-related issues, contact your broker or the relevant authorities directly.
This article is based on publicly available sources and is provided for informational purposes only. It may contain inaccuracies or outdated information and does not constitute financial or investment advice or a recommendation to buy, sell, or hold any securities.
Always conduct your own research and consult qualified professionals before making investment decisions. For official information, refer directly to the relevant companies or authorities.
